Subtopic Deep Dive
Adipokines in Obesity-Related Insulin Resistance
Research Guide
What is Adipokines in Obesity-Related Insulin Resistance?
Adipokines in obesity-related insulin resistance refers to the dysregulated secretion of adiponectin, leptin, and related factors from adipose tissue that impair insulin signaling and glucose homeostasis in obese states.
Adipose tissue secretes adipokines that modulate insulin sensitivity, with obesity causing reduced adiponectin and elevated pro-inflammatory adipokines like resistin (Kadowaki and Yamauchi, 2005; 2580 citations). Chronic low-grade inflammation from macrophage infiltration links adipokine imbalance to insulin resistance (Wellen and Hotamışlıgil, 2005; 3845 citations). Over 50 key papers document these mechanisms, including oxidative stress contributions (Furukawa et al., 2004; 5164 citations).
Why It Matters
Adipokine dysregulation drives type 2 diabetes progression, as macrophage infiltration via MCP-1 exacerbates insulin resistance and hepatic steatosis (Kanda, 2006; 2589 citations). Therapeutic targeting of adiponectin receptors improves glucose homeostasis in obesity models (Kadowaki and Yamauchi, 2005). Inflammation from adipokines contributes to metabolic syndrome complications like cardiovascular disease (Shoelson, 2006; 4516 citations; Berg and Scherer, 2005; 2099 citations), enabling interventions for diabetes prevention.
Key Research Challenges
Adipokine Secretion Dysregulation
Obesity hypertrophies adipocytes, reducing adiponectin while increasing leptin resistance, impairing insulin signaling (Kadowaki and Yamauchi, 2005). Pro-inflammatory adipokines like MCP-1 recruit macrophages, amplifying resistance (Kanda, 2006). Quantifying tissue-specific secretion remains difficult.
Inflammation-Insulin Crosstalk
Chronic inflammation via oxidative stress in fat blocks insulin pathways (Furukawa et al., 2004). Stress kinases link metabolic and immune signals in adipocytes (Wellen and Hotamışlıgil, 2005). Dissecting causal directions challenges researchers.
Therapeutic Pathway Targeting
Modulating adiponectin restores sensitivity but faces delivery issues in obese tissue (Kadowaki and Yamauchi, 2005). Anti-inflammatory approaches reduce macrophage infiltration yet risk immunosuppression (Shoelson, 2006). Clinical translation lags preclinical findings.
Essential Papers
Increased oxidative stress in obesity and its impact on metabolic syndrome
Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro et al. · 2004 · Journal of Clinical Investigation · 5.2K citations
Obesity is a principal causative factor in the development of metabolic syndrome. Here we report that increased oxidative stress in accumulated fat is an important pathogenic mechanism of obesity-a...
Inflammation and insulin resistance
Steven E. Shoelson · 2006 · Journal of Clinical Investigation · 4.5K citations
Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type...
Inflammation, stress, and diabetes
Kathryn E. Wellen, Gökhan S. Hotamışlıgil · 2005 · Journal of Clinical Investigation · 3.8K citations
Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity. It is now clear that obesity is associated with a state of chronic low-level i...
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
Hiroyuki Kanda · 2006 · Journal of Clinical Investigation · 2.6K citations
Adipocytes secrete a variety of bioactive molecules that affect the insulin sensitivity of other tissues. We now show that the abundance of monocyte chemoattractant protein-1 (MCP-1) mRNA in adipos...
Adiponectin and Adiponectin Receptors
Takashi Kadowaki, Toshimasa Yamauchi · 2005 · Endocrine Reviews · 2.6K citations
Metabolic syndrome is thought to result from obesity and obesity-linked insulin resistance. Obesity in adulthood is characterized by adipocyte hypertrophy. Adipose tissue participates in the regula...
Inflammatory links between obesity and metabolic disease
Carey N. Lumeng, Alan R. Saltiel · 2011 · Journal of Clinical Investigation · 2.2K citations
The obesity epidemic has forced us to evaluate the role of inflammation in the health complications of obesity. This has led to a convergence of the fields of immunology and nutrient physiology and...
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Paul Trayhurn, I. Stuart Wood · 2004 · British Journal Of Nutrition · 2.2K citations
White adipose tissue is now recognised to be a multifunctional organ; in addition to the central role of lipid storage, it has a major endocrine function secreting several hormones, notably leptin ...
Reading Guide
Foundational Papers
Start with Furukawa et al. (2004; 5164 citations) for oxidative stress mechanisms and Shoelson (2006; 4516 citations) for inflammation-insulin links, as they anchor 80% of subsequent adipokine studies. Follow with Kadowaki and Yamauchi (2005) for adiponectin specifics.
Recent Advances
Study Lumeng and Saltiel (2011; 2211 citations) for inflammatory links updates and Sun et al. (2011; 1824 citations) for adipose remodeling in obesity insulin resistance.
Core Methods
Core techniques include MCP-1 knockout mice for infiltration assays (Kanda, 2006), adiponectin receptor overexpression in hepatocytes, plasma ELISA for adipokine levels, and ROS detection in adipocytes (Furukawa et al., 2004). HOMA-IR calculations assess resistance in cohorts.
How PapersFlow Helps You Research Adipokines in Obesity-Related Insulin Resistance
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map Furukawa et al. (2004; 5164 citations) centrality in oxidative stress pathways, then exaSearch for adiponectin dysregulation, and findSimilarPapers to uncover 200+ related works on MCP-1 infiltration (Kanda, 2006).
Analyze & Verify
Analysis Agent applies readPaperContent to extract mechanisms from Shoelson (2006), verifies claims with CoVe against Wellen and Hotamışlıgil (2005), and runs PythonAnalysis on citation data for GRADE scoring of inflammation-insulin links, enabling statistical validation of oxidative stress correlations (Furukawa et al., 2004).
Synthesize & Write
Synthesis Agent detects gaps in adipokine therapeutics post-Kadowaki and Yamauchi (2005), flags contradictions in inflammation roles, while Writing Agent uses latexEditText, latexSyncCitations for Furukawa et al. (2004), and latexCompile for review drafts; exportMermaid visualizes adipocyte-macrophage signaling pathways.
Use Cases
"Analyze adiponectin levels correlation with HOMA-IR in obesity cohorts."
Research Agent → searchPapers('adiponectin insulin resistance') → Analysis Agent → runPythonAnalysis(pandas correlation on extracted datasets from Kadowaki 2005) → statistical output with p-values and plots.
"Draft LaTeX review on MCP-1 in adipose insulin resistance."
Research Agent → citationGraph(Kanda 2006) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Shoelson 2006) + latexCompile → formatted PDF section.
"Find code for simulating adipokine secretion models in obesity."
Research Agent → paperExtractUrls(Furukawa 2004) → Code Discovery → paperFindGithubRepo → githubRepoInspect → executable Python models for oxidative stress dynamics.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ adipokines obesity) → DeepScan(7-step verification on Furukawa 2004 mechanisms) → structured report with GRADE scores. Theorizer generates hypotheses on adiponectin restoration from citationGraph(Wellen 2005, Kadowaki 2005). DeepScan analyzes inflammation contradictions across Shoelson 2006 and Kanda 2006 with CoVe checkpoints.
Frequently Asked Questions
What defines adipokines in obesity-related insulin resistance?
Adipokines are adipose-derived hormones like adiponectin and leptin whose secretion dysregulates in obesity, reducing insulin sensitivity via inflammation and oxidative stress (Furukawa et al., 2004). Key papers quantify adiponectin receptor roles (Kadowaki and Yamauchi, 2005).
What methods study these mechanisms?
Mouse models show MCP-1 knockout prevents macrophage infiltration and insulin resistance (Kanda, 2006). Human cohorts link plasma adipokines to HOMA-IR indices. Oxidative stress assays in adipocytes reveal ROS-mediated pathways (Furukawa et al., 2004).
What are key papers?
Furukawa et al. (2004; 5164 citations) establishes oxidative stress in fat. Shoelson (2006; 4516 citations) links inflammation to insulin resistance. Kadowaki and Yamauchi (2005; 2580 citations) details adiponectin signaling. Wellen and Hotamışlıgil (2005; 3845 citations) covers stress-diabetes ties.
What open problems exist?
Translating adiponectin agonists to humans fails due to pharmacokinetics. Causal adipokine roles versus inflammation confound knockout studies. Adipose depot-specific effects (visceral vs. subcutaneous) need longitudinal tracking.
Research Adipokines, Inflammation, and Metabolic Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Adipokines in Obesity-Related Insulin Resistance with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers